Recombinant 2019 nCoV Antigens reagents

About

Recombinant Antigens reagents, Recombinant Coronavirus antigens, Coronavirus Protein, COVID-19 antigens, COVID-19 protein, SARS2 coronavirus, Recombi

COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly. Genemedi is a biotech company with strong expertise in viral vectors mediated gene transfer, gene editing and gene therapy. More detail please visit https://www.genemedi.net/i/recombinant-2019-ncov-antigens-reagents